axicabtagene ciloleucel
gilead sciences,daiichi sankyo
['axi-cel']
moffitt's presents at #asco22 on outcomes of axi-cel for the treatment of #lbcl by race and ethnicity. check it out at 3 p.m. cdt today. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.